Brett A. Giffin, Chief Commercial Officer at T2 Biosystems, Inc. (TTOO), bought 10,600 shares at $0.49 ($5K) on 2022-04-08, disclosed to the SEC on 2022-04-11.
Open-market purchase of $5k TTOO by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TTOO | SELL | 2022-11-22 | $2K | — | Filing → |